Showing results (51-60 of 97) with videos related to

Sort By:
Pageof 10
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 8, 2020
Iron kinetics following treatment with sucroferric oxyhydroxide or ferric citrate in healthy rats and models of anaemia, iron overload or inflammationJürgen Floege, Felix Funk, Markus Ketteler, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 26, 2016
Iron-related parameters in dialysis patients treated with sucroferric oxyhydroxideAdrian C Covic, Jürgen Floege, Markus Ketteler, et al.
Nephron|June 26, 2020
Characteristics of Patients Who Achieve Serum Phosphorus Control on Sucroferric Oxyhydroxide or Sevelamer Carbonate: A post hoc Analysis of a Phase 3 StudyAdrian C Covic, Stuart M Sprague, Anjay Rastogi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 9, 2004
Paricalcitol-treated patients experience improved hospitalization outcomes compared with calcitriol-treated patients in real-world clinical settingsDeborah G Dobrez, Angelo Mathes, Michael Amdahl, et al.
American Journal of Nephrology|July 20, 2016
Pharmacodynamic Effects of Sucroferric Oxyhydroxide and Sevelamer Carbonate on Vitamin D Receptor Agonist Bioactivity in Dialysis PatientsStuart M Sprague, Adrian C Covic, Jürgen Floege, et al.
Transplantation|October 27, 2004
Calcium and calcitriol prophylaxis attenuates posttransplant bone lossMichelle A Josephson, L Philip Schumm, May Y Chiu, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 2, 2008
Management of secondary hyperparathyroidism in stages 3 and 4 chronic kidney diseaseDennis L Andress, Daniel W Coyne, Kamyar Kalantar-Zadeh, et al.
American Journal of Nephrology|January 23, 2019
Cortical Perfusion and Tubular Function as Evaluated by Magnetic Resonance Imaging Correlates with Annual Loss in Renal Function in Moderate Chronic Kidney DiseasePottumarthi V Prasad, Lu-Ping Li, Jon M Thacker, et al.
American Journal of Nephrology|August 27, 2024
Sustained Reduction of Elevated Intact Parathyroid Hormone Concentrations with Extended-Release Calcifediol Slows Chronic Kidney Disease Progression in Secondary Hyperparathyroidism PatientsCharles W Bishop, Akhtar Ashfaq, Stephen A Strugnell, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 31, 2018
Effects of sucroferric oxyhydroxide and sevelamer carbonate on chronic kidney disease-mineral bone disorder parameters in dialysis patientsMarkus Ketteler, Stuart M Sprague, Adrian C Covic, et al.
Pageof 10